[1] DENG Y. Rectal Cancer in Asian vs. Western Countries: Why the Variation in Incidence?[J].Curr Treat Options Oncol,2017,18(10):64.
[2] SCOTT L J. Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers[J].Drugs,2018,78(7):747-758.
[3] 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学会分会.中国结直肠癌诊疗规范(2015版)[J].中华普通外科学文献(电子版),2015,9(6):506-523.
[4] KHALFALLAH M, DOUGAZ W, JERRAYA H, et al. Prognostic factors in rectal cancer: where is the evidence?[J].Tunis Med,2017,95(2):79-86.
[4] 李娜,黄琦,张明军, 等.安罗替尼三线治疗晚期转移性结直肠癌疗效分析[J].中华医学杂志,2019,99(36):2844-2847.
[5] SIVEEN K S, PRABHU K, KRISHNANKUTTY R, et al. Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges[J].Curr Vasc Pharmacol,2017,15(4):339-351.
[6] SCOTT L J. Apatinib: a review in advanced gastric cancer and other advanced cancers[J].Drugs,2018,78(7):747-758.
[7] LU W, KE H, QIANSHAN D, et al. Apatinib has anti-tumor effects and induces autophagy in colon cancer cells[J].Iran J Basic Med Sci,2017,20(9):990-995.
[8] LIU K, REN T, HUANG Y, et al. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma[J].Cell Death Dis,2017,8(8):e3015.
[9] JIN Z, CHENG X, FENG H, et al. Apatinib inhibits angiogenesis via suppressing Akt/GSK3beta/ANG signaling pathway in anaplastic thyroid cancer[J].Cell Physiol Biochem,2017,44(4):1471-1484.
[10] 包久铭,高艳梅,邱华凉, 等.甲磺酸阿帕替尼片联合卡培他滨片和奥沙利铂注射剂治疗晚期结直肠癌的临床研究[J].中国临床药理学杂志,2019,35(15):1565-1567.
[11] CHENG X, FENG H, WU H, et al. Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer[J].Cancer Lett,2018,431(2):105-114. |
2021, Vol. 38 
